Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTU-MultiHIV B Clade Vaccine in HIV-Infected Patients
NCT02457689Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Opal-HIV-Gag(c) in human immunodeficiency virus infection (HIV), sponsored by Imperial College London. Started Jul 2015; status: completed.
02
Drugs
Opal-HIV-Gag(c)
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02457689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457689.